Ghisallo Capital Management’s Disc Medicine IRON Stock Holding History

Ghisallo Capital Management’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$639K	–	349
2026 Q1	$639K	Hold	10,000	–	–	0.02%	248
2025 Q4	$794K	Buy	+10,000	New	+$845K	0.04%	185
2025 Q2	–	Sell	-25,000	Closed	-$1.24M	–	190
2025 Q1	$1.24M	Buy	+25,000	New	+$1.39M	0.11%	90
2023 Q3	–	Sell	-20,000	Closed	-$888K	–	143
2023 Q2	$888K	Buy	+20,000	New	+$710K	0.11%	97

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ghisallo Capital Management's IRON Position: Q2 2026 in Review

Ghisallo Capital Management sold out of Disc Medicine (IRON) in Q2 2026, closing a stake of 10,000 shares — an estimated $639K sold.

Ghisallo Capital Management first reported a position in IRON in Q2 2023 and held it in 4 quarters. The position peaked at $1.24M in Q1 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Ghisallo Capital Management reported no remaining Disc Medicine position as of Q2 2026 after selling out during the quarter.
Ghisallo Capital Management sold 10,000 Disc Medicine shares in Q2 2026, an estimated $639K.
Ghisallo Capital Management first reported a position in Disc Medicine in Q2 2023 and held it in 4 quarters.
Ghisallo Capital Management's Disc Medicine position peaked at $1.24M in Q1 2025.
216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.